Supplements
This product scores low overall due to its status as an unapproved, unregulated injectable peptide mimicking FDA-approved Scenesse (afamelanotide implant for EPP only), with historical FDA enforcement against cosmetic sales. Effectiveness is moderate (50/100) based on small tanning trials (e.g., JAMA Dermatol 2004: 0.16mg/kg/day SC + UV induced profound tanning in healthy volunteers, sustained >11 weeks) but lacks robust cosmetic RCTs and Examine.com data. Safety (25/100) hampered by AEs (nausea
Avoid this unregulated Melanotan 1 injectable for tanning; limited evidence doesn't outweigh safety/legal risks. Use FDA-approved Scenesse implant only for prescribed EPP treatment. Safer alternatives: topical self-tanners.